Crossmark

Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage

Crossref DOI link: https://doi.org/10.1038/s41419-022-05520-2

Published Online: 2023-02-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tseng, Kuan-Yin

Stratoulias, Vassilis

Hu, Wei-Fen

Wu, Jui-Sheng

Wang, Vicki

Chen, Yuan-Hao

Seelbach, Anna https://orcid.org/0000-0002-7908-7369
Huttunen, Henri J.

Kulesskaya, Natalia https://orcid.org/0000-0001-5517-8525
Pang, Cheng-Yoong https://orcid.org/0000-0002-9063-2858
Chou, Jian-Liang

Lindahl, Maria

Saarma, Mart https://orcid.org/0000-0001-5543-7160
Huang, Li-Chuan

Airavaara, Mikko https://orcid.org/0000-0002-2026-1609
Liew, Hock-Kean https://orcid.org/0000-0002-5981-4100
License Information

Text and Data Mining valid from 2023-02-15

Version of Record valid from 2023-02-15
More Information

Article History

Received: 3 June 2022

Revised: 12 December 2022

Accepted: 14 December 2022

First Online: 15 February 2023

Competing interests

: HH and NK are employees of Herantis Pharma Plc which sponsored part of this study and manufactured the rhCDNF protein. HH, NK, and MS are holders of Herantis Pharma shares and/or option rights.

Document is current

Any future updates will be listed below